Paul Shekelle, MD, PhD
CP Childers, MD;
Melinda Maggard Gibbons, MD, MSHS;
Jesus G. Ulloa, MD, MBA;
Ian T. Macqueen, MD
Isomi M. Miake-Lye, PhDc;
Roberta Shanman, MLS;
Jessica M. Beroes, BS
Evidence-based Synthesis Program (ESP) Center, West Los Angeles VA Medical Center, Los Angeles, CA
Washington (DC): Department of Veterans Affairs; June 2017.
The perioperative management of antiplatelet therapy for patients with coronary stents remains unclear. This review was requested to assess the evidence for the following key questions:
1.Among patients on APT in conjunction with percutaneous coronary intervention (PCI)undergoing elective surgical procedures, including intraocular procedures, what are the benefits and harms of holding APT prior to surgery?
2.How does benefit/risk vary by the timing of discontinuation?
3.How does benefit/risk vary by type of surgical procedure, including intraocular procedures?
4.How does benefit/risk vary by type of APT?
5.How does benefit/risk vary by the timing of resuming APT?
Childers CP, Maggard-Gibbons M, Shekelle PG. Antiplatelet Therapy in Patients with Coronary Stents Undergoing Elective Noncardiac Surgery: Continue, Stop, or Something in Between? Journal of the American Medical Association. Published online June 19, 2017. doi:10.1001/jama.2017.7845